MedPath

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

Not Applicable
Completed
Conditions
Morbid Obesity
Interventions
Dietary Supplement: Very low calorie diet
Registration Number
NCT03553849
Lead Sponsor
Christiana Care Health Services
Brief Summary

The investigators are studying the use of a two-week very low calorie diet (VLCD) in obese general surgery patients in a randomized single-blinded trial. The investigators hypothesize that the VLCD will positively impact the perceived surgical difficulty, operative time, hospital length of stay and 30-day complications. Additionally, the investigators anticipate reduced perioperative blood glucose levels and a reduced need for perioperative insulin administration.

Detailed Description

The investigators' objective for this project is to determine the impact of a preoperative VLCD on outcomes for patients undergoing elective general surgery. Included are patients who are obese, BMI \>30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery. Eligible patients are those scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.

The investigators will also be determining the feasibility of introducing a preoperative VLCD for patients undergoing elective general surgery in a Community Hospital setting.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • Patients who are obese, BMI >30, and scheduled by a Christiana Care-employed general surgeon for elective general surgery.
  • Patients between the ages of 18 and 65.
  • Patients scheduled for elective cholecystectomy, ventral or incisional hernia, umbilical hernia, and inguinal hernia surgery.
Exclusion Criteria
  • Patients will be excluded from the study if they have any of the following:

    1. Recent myocardial infarction (3-6 months).
    2. History of cerebral vascular accident (stroke).
    3. Diabetes mellitus with a history of severe ketoacidosis.
    4. Patients on SGLT2 inhibitors (glifozins) without insulin
    5. Chronic use of steroids, greater than 20mg daily.
    6. Bleeding peptic ulcer (unless there is radiological evidence of healing 6 months prior to entry).
    7. A psychiatric history that includes suicide attempts and anyone taking psychotropic drugs, including lithium carbonate.
    8. Active thrombophlebitis (or any other condition where decreased blood volume would put the patient at risk).
  • In addition, patients who are pregnant are excluded. If status is unknown, a pregnancy test will be required prior to the start of the VLCD.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Very Low Calorie DietVery low calorie dietIf they are randomized into the treatment arm, they will be prescribed with a 2-week VLCD that will begin 2 weeks prior to the scheduled elective surgery. Patients will be required to pay for the meal replacements.
Primary Outcome Measures
NameTimeMethod
Reduction in Post Operative Complications30-days post operatively

Pulmonary, cardiac and surgical complications using data collected from inpatient and outpatient charting

Secondary Outcome Measures
NameTimeMethod
Feasibility of the Study2 weeks

Patient satisfaction and compliance based on patient surveys administered prior to discharge from the hospital

Effect on Perioperative BMI2 weeks

Difference in pre operative and perioperative BMI, in kg/m\^2

Effect on operative timesDay of surgery

Comparative operative times, in minutes, between control and intervention

Effect on blood glucose levels2 weeks

Difference in pre operative and perioperative blood glucose levels

Effect on surgeon perceived difficultyDay of surgery

Comparative surgeon perceived difficulty between control and intervention utilizing a surgeon and procedure specific survey

Effect on insulin administration2 weeks

Difference in pre operative and perioperative insulin administration, in units

Effect on operative blood lossDay of surgery

Comparative operative blood loss, in milliliters, between control and intervention

Trial Locations

Locations (1)

Christiana Care Health System

🇺🇸

Newark, Delaware, United States

© Copyright 2025. All Rights Reserved by MedPath